Status:
COMPLETED
High Energy Density Pulse Electromagnetic Field for Patients With Adhensive Capsulitis
Lead Sponsor:
Tri-Service General Hospital
Conditions:
Adhesive Capsulitis
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The aim of our study is to investigate the efficacy of high energy density pulse electromagnetic field for patients with adhesive capsulitis
Detailed Description
Adhesive capsulitis, a condition causing shoulder pain and limited range of motion (ROM), is estimated to affect 2-5% of the general population. Typically occurring in middle-aged individuals during t...
Eligibility Criteria
Inclusion
- Physicians diagnose frozen shoulder by considering the patient's medical background, conducting a physical assessment, and reviewing X-ray and ultrasound findings.
- The symptoms endure for a duration exceeding 3 months.
- There exists a decrease of no less than 30 degrees in a minimum of two joint angles of the affected shoulder, namely flexion, abduction, and external rotation, in comparison to the corresponding angles of the unaffected side.
Exclusion
- Musculoskeletal ultrasound of the shoulder identifies a full-thickness tear or substantial tear in the rotator cuff tendons or presents calcific tendinitis.
- Presence of systemic rheumatic disease.
- Prior history of shoulder fracture or surgical intervention involving the shoulder joint.
- Acute compression of cervical nerve root.
- Patients displaying instability (e.g., those with signs of internal bleeding) or individuals with cancer.
- Recent receipt of shoulder injections for treatment within the last 3 months.
- Impaired cognitive function that hinders the patient's ability to provide informed consent or engage in rehabilitation therapy.
- Expectant or breastfeeding women.
- Meets any of the contraindications for high-energy electromagnetic pulse therapy: individuals with organ transplants, implanted cardiac pacemakers, defibrillators, metal implants (such as stents), cochlear implants, and those requiring insulin supplementation.
Key Trial Info
Start Date :
February 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT06000254
Start Date
February 21 2024
End Date
December 31 2024
Last Update
January 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tri-service general hospital
Taipei, Taiwan